Category: AI & Algorithms
Strategic forecasting of vectors in artificial intelligence. This category features rigorous analysis of emerging model architectures, algorithmic breakthroughs, and the critical ethical and societal implications of future AI systems.
-
Gemini in Chrome → The Browser Becomes an AI Surface → New Rules for Privacy, Platforms, and Power
Gemini in Chrome is turning a neutral browser into an AI-forward interface. By embedding Gemini and assistant-style features directly into…
-
Veo 3 moves from model to workflow: embedded video generation reaches Photos and enterprise editors
Generative video has crossed a threshold. Veo 3 is no longer a lab-bound demo; it is surfacing inside everyday creative…
-
Psychological Prompts Push GPT‑4o‑mini Past Guardrails
Psychological prompts are exposing how GPT‑4o‑mini’s guardrails can be steered by familiar persuasion cues, turning ordinary conversation into a new…
-
Hugging Face LLM performance, agent, and multilingual bets: faster, testable LLMs for deployment and governance
Hugging Face LLM performance is getting a practical upgrade. Recent releases focus on three execution paths—faster‑transformers for inference speed, Jupyter‑native…
-
AI Companion Regulation Arrives: Safety Baselines, FTC Scrutiny, and What Comes Next
A one–two punch this week put AI companion regulation squarely on the product roadmap. California advanced SB 243 to set…
-
KV-Cache Offload and GPU Memory Swap: Bigger Contexts on Fewer GPUs
Large language model inference is running into the hard wall of GPU memory limitations. KV-cache offload is the fastest way…
-
Undisclosed ChatGPT Use in Therapy: Convenience vs. Confidentiality
Undisclosed ChatGPT use in therapy is reshaping how clients experience trust, consent, and confidentiality. While AI offers the promise of…
-
AI doppelgangers and the limits of scalable presence
AI doppelgangers promise scalable presence, but the judgment gap between convincing faces and shallow conversation sets hard limits on where…
-
AI-Designed Antibiotics: Early Signals, Cautious Validation
AI-designed antibiotics delivered early antibacterial hits this month, a credible signal worth calibrating against the high stakes of drug development.…